Day 2
Thursday, 10 January 2019
3rd Session: Translators
Chairs: Holger Gerhardt (Berlin) | Stephan Felix (Greifswald)
| 08:30 - 09:00 | Bert Klebl, Dortmund | LDC – A (proven) model for bridging academia to “pharmaceutical industry” |
| 09:00 - 09:30 | Jérôme Van Biervliet, Ghent | Basic science, translational medicine and how to translate to value: The VIB experience |
| 09:30 - 10:00 | Timothy McKinsey, Aurora | Early Translation in Academia: Drugging the Unthinkable for Heart Failure |
| 10:00 - 10:30 | Coffee break |
4th Session: Translational Projects | DZHK
Chairs: Alexandra Lansky (New Haven) | Garret A. FitzGerald (Philadelphia)
| 10:30 - 10:45 | Stefan Luther, Göttingen | Low energy defibrillation |
| 10:45 - 11:00 | Florian Weinberger, Hamburg | Engineered heart tissue transplantation for cardiac repair – towards first-in-patient |
| 11:00 - 11:15 | Esther Lutgens, Munich | CD40-TRAF6 inhibitors in Cardiovascular disease |
| 11:15 - 11:30 | Patrick Most, Heidelberg | Peptide-based therapy development for cardiac failure treatment |
| 11:30 - 11:45 | Lucie Carrier, Hamburg | Gene therapy for myofilament disorders |
| 11:45 - 12:00 | Wolfram-Hubertus Zimmermann, Göttingen | GMP-Production of engineered human myocardium for heart failure repair |
12:00 - 13:00: Lunch break
13:00 - 14:00: 2nd parallel poster session (No. 16-25 / No. 26-35)
5th Session: Biotech
Chairs: Ingrid Fleming (Frankfurt am Main) | Thorsten Kessler (Munich)
| 14:00 - 14:30 | Martin Ungerer, Munich | Development of biologicals |
| 14:30 - 15:00 | Craig January, Madison | The CDI Story |
| 15:00 - 15:30 | Kenneth Walsh, Virginia | Killer Clones: Clonal Hematopoiesis and Age-associated Disease |
| Concluding remarks | Gerd Hasenfuß, Göttingen | |
| Coffee & Goodbye |
The talk by John T. Gray was regretfully cancelled.
6th Session: Path to discovery
The talk by Graziella Pellegrini was regretfully cancelled. Kenneth Walsh will give his talk in the 5th session.